JPRN-jRCT2080220828未知2 期
A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/ Tolerability and Pharmacokinetics of Five Dose Levels of R7201/CSG452 in Patients With Type 2 Diabetes Mellitus
Chugai Pharmaceutical Co., Ltd. , Hoffmann-La Roche0 个研究点目标入组 300 人开始时间: 2009年8月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •type 2 diabetes, diagnosed for >=3 months;
- •- either treated with diet, exercise and stable metformin, or with diet and exercise alone.
排除标准
- •- type 1 diabetes mellitus
- •- currently or within 2 months prior to screening treated with an oral or injectable anti-diabetic agent except stable doses of metformin
- •- currently or within 6 months prior to screening treated with any PPARgamma agonist
- •- uncontrolled hypertension
- •- significant pre-diagnosed diabetic complications requiring treatment
研究者
相似试验
进行中（未招募）
1 期
Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)Eosinophilic Gastritis and/or GastroenteritisMedDRA version: 23.0Level: PTClassification code 10083619Term: Eosinophilic gastritisSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.1Level: PTClassification code 10017902Term: Gastroenteritis eosinophilicSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-000085-14-DEAstraZeneca AB230
进行中（未招募）
1 期
Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)Eosinophilic Gastritis and/or GastroenteritisMedDRA version: 23.0Level: PTClassification code 10083619Term: Eosinophilic gastritisSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 20.1Level: PTClassification code 10017902Term: Gastroenteritis eosinophilicSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2021-000085-14-PLAstraZeneca AB230
招募中
2 期
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension PatientsResistant HypertensionJPRN-jRCT2031220454Yamada Hiroyuki10
进行中（未招募）
1 期
Efficacy and Safety of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)EUCTR2021-000085-14-ITASTRAZENECA AB230
进行中（未招募）
1 期
Clinical research study of an investigational new drug to treat moderate to severe persistent asthma with type 2 inflammatioModerate to Severe Persistent Asthma with Type 2 InflammationEUCTR2021-000583-30-HUSuzhou Connect Biopharmaceuticals Ltd.306